UCAM and IMIB patent a new use for two drugs to prevent and treat covid-19
Researchers from the two institutions have carried out in-vitro development with Zeaxanthin and Kukoamine A to prevent the virus from entering the cell
Murcian researchers achieve important advances in the fight against arthritis, alzheimer and diabetes
The ‘Nature Chemical Biology’ magazine, from the prestigious group Nature, published recently the results from the researchers from the Murcian Institution of Biosanitary Research of Arrixaca in collaboration with scientists from UCAM and the Hospital Clinic-IDIPBAS, that have discovered the action mechanism of the anti-inflammatory molecule that allows to develop new treatments against arthritis, alzheimer and diabetes